chrisvoncsefalvay/vaers-outcomes huggingface dataset:
After getting the first shot, I was very tired, I slept for 17 hours waking once after 9 hours for bathroom.  The next day under my left arm was sore for several days.  After the second shot on 4/17/21, I was tired. Under my left arm I had a large mass (swelling) that was very painful. The swelling lasted for three days.  Now (4/25/21) I have pain under my right arm. Presently I do not see any swelling or feel anything , just pain.
throat was swollen; hard time trying to swallow; hard time trying  to breath; headache; nausea; fever, close to 104°F after the third dose; had pain in their muscles/body aches/body pain still,; pain in their  joints; developed a very strong reaction with a wide range of symptoms; everything was painful, painful to lay down, painful to walk; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION COMPLICATION (developed a very strong reaction with a wide range of symptoms), PAIN (everything was painful, painful to lay down, painful to walk), PHARYNGEAL SWELLING (throat was swollen), DYSPHAGIA (hard time trying to swallow) and DYSPNOEA (hard time trying  to breath) in a 59-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 027D21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Immunocompromised and Scleroderma. Concomitant products included LOSARTAN POTASSIUM (AVANTAR) for an unknown indication.    On 20-Aug-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 20-Aug-2021, the patient experienced VACCINATION COMPLICATION (developed a very strong reaction with a wide range of symptoms), PAIN (everything was painful, painful to lay down, painful to walk), MYALGIA (had pain in their muscles/body aches/body pain still,) and ARTHRALGIA (pain in their  joints). On 20-Aug-2021 at 7:30 PM, the patient experienced PYREXIA (fever, close to 104°F after the third dose). On 21-Aug-2021, the patient experienced HEADACHE (headache) and NAUSEA (nausea). On 22-Aug-2021, the patient experienced PHARYNGEAL SWELLING (throat was swollen), DYSPHAGIA (hard time trying to swallow) and DYSPNOEA (hard time trying  to breath). The patient was treated with PARACETAMOL (TYLENOL) on 21-Aug-2021 for Pain, at a dose of 1 dosage form. On 24-Aug-2021, VACCINATION COMPLICATION (developed a very strong reaction with a wide range of symptoms), PAIN (everything was painful, painful to lay down, painful to walk), PHARYNGEAL SWELLING (throat was swollen), DYSPHAGIA (hard time trying to swallow), DYSPNOEA (hard time trying  to breath), PYREXIA (fever, close to 104°F after the third dose), MYALGIA (had pain in their muscles/body aches/body pain still,), ARTHRALGIA (pain in their  joints), HEADACHE (headache) and NAUSEA (nausea) had resolved.            This case was linked to MOD-2021-294965 (Patient Link).
She received her second dose of the Pfizer Covid vaccine on 5/27 and had expected fatigue/chills/myalgias for the first 2 days.  On Sunday evening she developed a full-body rash which started on her back and torso.  The rash was itchy, small, red, raised lesions which coalesced into multiple patches on her bilateral upper and lower extremities.  The rash is worst now on her lower extremities.  She took one half of a tablet of Benadryl at 11:00.  She began to develop left-sided angioedema of her lips and bilateral eyelid swelling.  She took a full tablet of Benadryl at 1600 and called to the nursing line for her PCP and was advised to present to the ED.  She did not have any trouble breathing.  She has no voice changes.  She did feel lightheaded this morning.  She has not felt nauseous or had vomiting or diarrhea.  She has had no new exposures, no new detergents/soaps/clothing, has not spent extra time outside.  She has no known allergies but notes sensitive skin and some food sensitivities. Upon arrival to the ED, she is afebrile with elevated heart rate and blood pressure, with normal oxygen saturation and no respiratory distress on room air.  On exam, she has bilateral eyelid swelling, mild left lip angioedema, and diffuse maculopapular rash.  Differential diagnosis includes anaphylaxis, vaccine reaction, allergic reaction to unknown allergen, viral process.  She shows no signs of severe anaphylaxis, shock, or respiratory compromise.  She was given cetirizine and famotidine for histamine blockade.  Based on the lack of other systemic symptoms, steroids were not indicated.
Patient called stating that he thinks he may have had a reaction to the oral typhoid vaccine that he started taking yesterday.  He states that he took the first dose as instructed (on empty stomach, swallowed whole and with cool water) and approximately 45 minutes later, he experience dizziness, felt faint and he noted facial numbness.  He states that he laid down and his symptoms resolved within approximately 15 minutes but he is now wondering if he should continue the subsequent doses or if he should not take any more.  He denies that he had any fever, rash, facial swelling, fast heart beat, difficulty swallowing or difficulty breathing.   Patient did not get any other vaccines yesterday (9/18/19).  The most recent vaccination was administered on 9/5/19 (Td)
SWOLLEN NODE ON RIGHT SIDE, FEVER, FATIGUE, HEAVY FOG, BODY ACHE, AND CHILLS.
This case was reported by a pharmacist via call center representative and described the occurrence of pain in arm in a female patient who received SHINGRIX (batch number 4LP5Y, expiry date 27th February 2021) and (batch number 293AT, expiry date 27th February 2021) for prophylaxis. On 27th August 2018, the patient received SHINGRIX. On an unknown date, the dose was an unknown dose. On 27th August 2018, immediately after receiving SHINGRIX, the patient experienced pain in arm, myalgia upper extremities and joint range of motion decreased. The patient was treated with anti-inflammatory/antirheumatic products and Heat Therapy. On an unknown date, the outcome of the pain in arm, myalgia upper extremities and joint range of motion decreased were not recovered/not resolved. It was unknown if the reporter considered the pain in arm, myalgia upper extremities and joint range of motion decreased to be related to SHINGRIX. Additional details were provided as follows: The age at vaccination was not reported. The patient began experiencing arm pain immediately after receipt of SHINGRIX. The muscle pain had been severe enough to interfere with range of motion. Anti-inflammatories and heat were tried with minimal improvement. At the time of reporting, the patient was undergoing physical therapy to help alleviate symptoms. The healthcare professional (HCP) did not feel comfortable providing patient's demographics. The reporter did not give consent to be followed up. The HCP would follow up after discussion with the patient if she changes her mind.
on 2/11/2021 I experienced  general lethargy and muscle aches.  On 2/13/2021 in late morning, I suffered shortness of breath, with increased intensity  and had to enter the ER.
Information has been received regarding a case in litigation from a lawyer and an estate representative of an 82 year-old deceased patient of unknown gender. No information was received regarding the patient's past medical history, concurrent conditions, or concomitant medication. The patient was prescribed the ZOSTAVAX vaccine by a healthcare provider for the long-term prevention of shingles and zoster-related conditions. In 2015, at approximately 80 years of age, the patient was administered the ZOSTAVAX by a pharmacist at a pharmacy (lot number, dosage and route of administration not provided). On an unknown date, the patient was treated by a physician at a family practice medical office for the following injury resulting from the ZOSTAVAX use: Shingles. The outcome of the shingles was unknown. It was also claimed that the patient died on 30-MAR-2018 at age 82 years old. Cause of death not provided. The patient claims damages as a result of: injury to themselves, wrongful death, survivorship action, and economic losses. Upon internal review, Death was determined to be a medically significant event. Additional information has been requested.; Reported Cause(s) of Death: Death.
Post vax, pt developed swelling at the injection site. He was seen in an ED where IV antibiotics was given. He was given a 10 day course of oral Keflex as well.
Swelling at vaccination site. Instructed to take Benadryl 25 mg PO if swelling persisted.
suspected vaccination failure/I got vaccinated several years back, and currently have what I consider an horrific case of Shingles.; horrific case of Shingles; This case was reported by a consumer via interactive digital media and described the occurrence of suspected vaccination failure in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. On an unknown date, several years after receiving Shingles vaccine, the patient experienced vaccination failure (serious criteria GSK medically significant) and shingles. On an unknown date, the outcome of the vaccination failure and shingles were unknown.   It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingles vaccine.  Additional details provided were as follows: The case was self-reported by the patient. The age at vaccination was not reported. The patient received a dose of Shingles vaccine several years back, and currently experienced a horrific case of Shingles. The patient would not wish this on anyone.  The patient hope that the current vaccine would be better than the one he/she got. Follow-up would not be possible as no contact details available. This case was considered as suspected vaccination failure since the details regarding completion of primary vaccination schedule, time to onset and laboratory test confirming shingles were unknown at the time of reporting.
AFTER GETTING THE FLU SHOT I WAS JUST SORE & MAYBE A WEEK LATER I NOTICED MY RANGE OF MOTION WAS LIMITED & MY ARM WAS A LITTLE MORE SENSATIVE. AFTER A COUPLE OF DAYS  THE SORENESS/SENSATIVE WENT AWAY BUT RANGE OF MOTION WAS STILL LIMITED.  SLOWLY MY SYMPTOMS ALL CAME BACK TENDERNESS/RANGE OF MOTION - BUT OVER THE WEEKEND I NOTICED MY LEFT ARM GETTING A BIT MORE SENSATIVE.  WHEN I CALLED OUR OCCUPATIONAL LINE THEY SAID IT HAS BEEN A LONG TIME PASSED SO I NEEDED TO DO THIS REPORT
Torn left knee meniscus.  Resulted in surgery to remove tear.  History of knee issues .  Don?t believe in any way related but I was told I needed to report it as I had surgery within a year of vaccine
Bell's palsy. Acute tension headache for two days prior, then physical symptoms of partial facial paralysis.
I believe that my 2nd shot for covid19 was given improperly. It was given up at the top of my left arm where my shoulder is.  When the alcohol was rubbed on my arm, I mentioned to the shot giver that I thought it was too high on my arm.  I pointed to where I had gotten my first shot which was into my deltoid muscle, perfectly.    She rubbed her finger on my arm and reapplied more alcohol and gave me my shot at the top of my arm above the deltoid muscle where my first shot had been properly given. This second shot was noteable in its discomfort, opposite of what was felt with my first vaccine shot 3 weeks prior.  I remarked shortly after to my husband that my shoulder was indeed becoming painful. By 5:30 pm, it was quite painful and I couldn?t move it normally without extreme discomfort.
Shingrix stored at temperatures ranged from 28 F to 56 F over the course of 6 months; This case was reported by a pharmacist via call center representative and described the occurrence of incorrect storage of drug in an unspecified number of patients who received Herpes zoster (Shingrix) for prophylaxis.   On 31st August 2022, the patients received Shingrix. On an unknown date, unknown after receiving Shingrix, the patients experienced incorrect storage of drug. On an unknown date, the outcome of the incorrect storage of drug was unknown.   Additional Information: GSK Receipt Date: 28-FEB-2023 Reporter's comment: The pharmacist reported that Shingrix stored at temperatures ranged from 28 F to 56 F over the course of 6 months. The reporter enquired that if patient was outside of 6 month window, should series be restarted.  The health care professional  was unsure when patients received vaccinations and if patients vaccinations were within stability range.  The HCP  reported that approximately 30 patients had been vaccinated since the issue started on 31st August 2022.  No patient demographic data available at time of reporting. The reporter consented to follow up. Additional supportive information: The Shingrix vaccines were stored at temperatures ranged from 28 F to 56 F over the course of 6 months, which led to incorrect storage of drug.
Shortly after the vaccination I felt lightheaded and was unable to focus on simple computer tasks and felt very tired and weak. Laid down could not focus on reading or viewing TV slept for several hours. The following day I tried to work after a breakfast of toast and coffee, but the symptoms of the previous day continued so I returned to bed and slept for the next 8 hours. When I woke-up I had what I would describe as flu-like symptoms body aches and chills. This lasted until early evening on the third day when I started to feel better. By the fourth day I felt well again.
PAIN AT INJECTION SITE; This spontaneous report received from a patient concerned a 32 year old male. The patient's height, and weight were not reported. The patient's concurrent conditions included alcoholic, and non smoker, and other pre-existing medical conditions included the patient had no known drug allergies and no relevant medical history. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, intramuscular, batch number: Unknown) dose was not reported, administered on 02-APR-2021 for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported. On 02-APR-2021, the subject experienced pain at injection site. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from pain at injection site on 04-APR-2021. This report was non-serious. This case, from the same reporter is linked to
ITCHING, SWELLING AND REDNESS IN A 6-8 INCH AREA BELOW INJECTION SITE. PATIENT TREATED IT WITH NSAIDS AND BENADRYL. NO FURTHER COMPLAINTS.
Weakness, fatigue, fever to 101, chills, muscle aches, shivers, joint pain, severe headache, nausea, loss of appetite lasting approximately 72 hours
pt recv vax 1OCT96 & 15OCT96 pt devel severe vomiting & diarrhea;p/2 days pt was eval in Er & was hydrated IV;MD felt that pt had food poisoning & should be adm but the pt chose to leave several hr later;stool specimen was positive for food
Fatigue; Injection site soreness; Right hip pain; This is a spontaneous report from a contactable Nurse. This 58-year-old female nurse (Patient) reported for herself that: A 58-years-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, lot number: ER8729), via an unspecified route of administration, administered in arm left on 13Apr2021 11:00 (at the age of 58-years-old) as DOSE 1, SINGLE for covid-19 immunization at physician office (reported as doctor's office/urgent care).  Medical history included eczema and endometriosis from an unknown date and unknown if ongoing. The patient was not pregnant at the time of vaccination. Concomitant medication(s) included ascorbic acid, betacarotene, cupric oxide, tocopheryl acetate, zinc oxide (PRESERVISION), estradiol, norethisterone acetate (COMBIPATCH), colecalciferol (D3) and nicotinamide, pyridoxine hydrochloride, riboflavin, thiamine hydrochloride (B COMPLEX [NICOTINAMIDE; PYRIDOXINE HYDROCHLORIDE; RIBOFLAVIN; THIAMINE HYDROCHLORIDE]) all were taken for an unspecified indication, start and stop date were not reported for any. The patient had no known allergies. The patient did not receive any other vaccines within 4 weeks. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 14Apr2021 08:00, the patient experienced fatigue, injection site soreness and right hip arm. (Reported AEs description: fatigue (mild, 4/18-4/19), injection site soreness (mild, 4/14-4/15) and right hip pain (moderate, 4/15-4/19; mild, 4/20-ongoing). The patient did not receive any treatment for the events. The outcome of events was recovering.  No follow-up attempts are possible. No further information is expected.
The following patient received a Moderna dose approved for 6-11 years of age on 10/07. This vial was originally approved as a booster dose for patients 18+. So technically, they received a monovalent booster.
Cant raise her arm for 4 days; Injection site pain; Tired for couple of weeks; May have got headache; This spontaneous case was reported by a consumer and describes the occurrence of MOBILITY DECREASED (Cant raise her arm for 4 days), VACCINATION SITE PAIN (Injection site pain), FATIGUE (Tired for couple of weeks) and HEADACHE (May have got headache) in a 77-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013AZ119) for COVID-19 vaccination.     The patient's past medical history included Arthritis (Arthritis on thumb on other arm.).    On 04-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced MOBILITY DECREASED (Cant raise her arm for 4 days), VACCINATION SITE PAIN (Injection site pain), FATIGUE (Tired for couple of weeks) and HEADACHE (May have got headache). At the time of the report, MOBILITY DECREASED (Cant raise her arm for 4 days), VACCINATION SITE PAIN (Injection site pain), FATIGUE (Tired for couple of weeks) and HEADACHE (May have got headache) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   This case was linked to MOD-2021-098667 (Patient Link).
Medium-sized lump on arm for 5+/- days. Asthma, present for several days before, became a bit worse, due to concurrent reflux from my GERD of long standing. Don't believe the Booster had to do with reason I was recommended to report, which was concerned I may have inspirated stomach acid to cause possible pneumonia. x-rays were negative for any impacts or congestion.
When we got home, he complaining his arm hurt. He ate, I gave him some ADVIL. He took his nightly bath, after bath I noticed it was hot touch on the arm. It was red and swollen as well. He  pushed back when I tried to touch it again. I put some vapor rub on there and he went to bed. The next morning when he woke up he complained again that his arm was hurting. Its was noticeably swollen more than the night before and more red, it was spreading down to elbow and inside his arm. I sent him to school but marked it with a marker. Nurse called at noon that his arm has gotten bigger and the mark it was starting to blister.
Information has been received from a Certified Medical Assistant for the Pregnancy Registry for GARDASIL concerning a 19 year old female with penicillin allergy who on 30-JUN-2008 was vaccinated with a 0.5 ml first dose of GARDASIL (LOT # 0250X) and on 29-AUG-2008 received a second dose of GARDASIL (LOT # 0573X). The reporter stated that the patient who had received the GARDASIL vaccine "is pregnant". Her LMP was 19-SEP-2008. Expected date of delivery is 26-JUN-2009. There was no concomitant medication. No adverse effect was reported. The patient was seen in the office for medical attention. Follow up information was received on 30-DEC-2008 from a certified medical assistant who stated that there was a elective termination of the pregnancy. It was unknown if the products of conception were examined or if the fetus was normal. Upon internal review, elective termination was considered to be an other important medical event. Additional information has been requested.
THE PATIENT PRESENTS RASH IN THE UPPER BODY. THIS HAPPENS 15 MINUTES AFTER ADMINISTRATION OF THE VACCINE.
up 21JAN97 w/fever 101, fever on & off;1 wk prior cold & congestion, no fever;24JAN woke up w/stiff neck & h/a, eyes red & light sensitive;taken to MD office then to ER;adm to hosp;dx viral meningitis;80% on 25JAN97 only sl h/a, t98.6
Headache; Sore arm; Tired; Joint aches; Administration date 12Oct2021, dose number=3; This is a spontaneous report from a contactable consumer, the patient. A 59-year-old male patient received the third dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: Unknown) via an unspecified route of administration in the left arm on 12Oct2021 at 12:00 (at the age of 59-years-old) as a single dose for COVID-19 immunisation. Medical history included atrial fibrillation and arthritis. The patient had no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications included acetylsalicylic acid (ASPIRIN); from an unknown date for an unknown indication and unknown if ongoing. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: Unknown) via an unspecified route of administration in the left arm on an unknown date, as a single dose for COVID-19 immunisation and also received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: Unknown) via an unspecified route of administration in the left arm on an unknown date, as a single dose for COVID-19 immunisation. On 12Oct2021 at 12:00, the patient had "administration date 12Oct2021, dose number=3". On 13Oct2021 at 10:00, the patient experienced headache, sore arm, tired and joint aches. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events headache, sore arm, tired and joint aches. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events headache, sore arm, tired and joint aches was not recovered. The clinical outcome of the event "administration date 12Oct2021, dose number=3" was unknown at the time of this report.  The lot number for BNT162b2 was not provided and will be requested during follow up.
Developed sxs ofIDP 4 days after multiple vaccines in training. Sxs effect both feet and both biceps. Had 1st round of IVIG in June 08, 6 months after initial sx development and has had some improvement. Is being medically separated from the military. Wears a breace on rt foot in order to walk. Symptoms: Weakness, Neuopathy.  8/8/08 Reviewed medical records for  12/2007-7/2008. FINAL DX: Idiopathic acute polyneuropathy Records reveal patient experienced weakness, paresthesias of lower extremities w/difficulty walking on 12/22/2007.  PT was not helpful.  Referred to neuro.  Condition progressed to include weakness & paresthesias of upper extremities & impairs activities of daily living.  Tx w/IVIG 6/2008 w/some improvement.
I received my shot in my left arm on the afternoon of the 11th of June.  In the days following, I began to have sore muscles in my left triceps and biceps and left neck/shoulder.  The arm pain continued for no more then a day, but the morning of the 17th I woke up, got out of bed, and my neck kinked.  The stiff neck was so severe that I could barely move it and it was incredibly painful the entire day.  I was forced to look down the entire day because lifting my head up was too painful.  I treated it with advil and vicodin and heat packs.  The pain went on for days (continuing to lessen) until the 23rd when I could no long feel any lingering neck pain.  I had never had a stiff neck last that long previously.